Financial Year |
March 31 2023 |
Monetary Funds |
211,862,039.88 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
1,611,467.74 |
Accounts Receivable |
25,139,585.92 |
Advances to Suppliers |
73,050,785.34 |
Other Receivables |
4,025,104.72 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
267,802,287.64 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
34,168,274.08 |
Total Current Assets |
617,659,545.32 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
2,277,161.12 |
Investment Properties |
403,450,913.25 |
Fixed Assetes |
289,069,011.62 |
Under-construction Projects |
153,655,418.11 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
51,312,030.66 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
2,626,216.92 |
Deferred Income Tax Assets |
31,021,858.94 |
Other Non-Current Assets |
162,554,371.50 |
Sub-Total of Non-Current Assets |
1,096,150,186.27 |
Total Assets |
1,713,809,731.59 |
Short-Term Loans |
154,211,457.50 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
45,801,587.04 |
Accounts Received In Advance |
5,951,648.48 |
Employee Compensation Payable |
8,165,580.50 |
Taxes Payable |
1,401,034.51 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
254,359,855.03 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
238,566.94 |
Other Current Liabilities |
879,900.01 |
Sub-Total of Current Liabilities |
485,968,417.04 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
5,271,294.07 |
Deferred Income Tax Liabilities |
499,393.03 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
15,062,673.06 |
Total Liabilities |
501,031,090.10 |
Paid-In Capital(Or Share Stock) |
377,310,718.00 |
Capital Surplus |
1,207,888,030.92 |
Surplus Reserve |
58,791,600.08 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-397,359,007.63 |
Minority Stockholder's Interest |
-29,822,881.99 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,242,601,523.48 |
Owner's Equity(Stockholder's Equity) |
1,212,778,641.49 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,713,809,731.59 |